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Male sexual differentiation relies upon testicular secretion of the hormones testosterone, Mullerian inhibiting substance,
and insulin-3 (Insl3). Insl3 is responsible for testicular descent through virilization and outgrowth of the embryonic
gubernaculum. In mouse, prenatal exposure to 17b-estradiol and the nonsteroidal synthetic estrogen diethylstilbestrol
(DES) disturbs the endocrine balance, causing demasculinizing and feminizing effects in the male embryo, including
impaired testicular descent (cryptorchidism). In the current study, we show that maternal exposure to estrogens, including
17a- and b-estradiol, as well as DES, specifically down regulates Insl3 expression in embryonic Leydig cells, thereby
providing a mechanism for cryptorchidism. These experiments may have implications for the widespread use of estrogenic
substances in agriculture and the environment. © 2000 Academic Press
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lINTRODUCTION
Testicular descent is an important aspect of male sexual
development. Failure of the testes to descent into the
scrotum (cryptorchidism) is one of the most common birth
defects in humans affecting approximately 3% of newborn
males. Cryptorchidism can result in infertility and is asso-
ciated with an increased risk for development of testicular
cancer (Hutson et al., 1994). In mice, while the ovaries form
and remain positioned just below the metanephros, the
testes undergo relocation in the scrotum. This descent
occurs in two distinct, hormonally regulated phases (Hut-
son, 1985; Hutson et al., 1994; Satokata et al., 1995). During
the transabdominal phase (embryonic day 15.5 (E15.5) to
E17.5) the testes relocate from the urogenital ridge to the
inguinal region. The gubernaculum, a mesenchymal tissue
that connects the urogenital ridge to the inguinal abdomi-
nal wall, mediates this transabdominal descent. Contrac-
tion of the gubernacular cord and outgrowth of the guber-
nacular bulb, concomitant with elongation of the
embryonic rostrocaudal axis, place the testes above the
inguinal canal at birth. In mice, the inguinoscrotal phase
(testicular migration into the scrotum) occurs in the second
or third postnatal week.
1 To whom correspondence should be addressed. E-mail:
aparada@utsw.swmed.edu.
354Different hormones control the two phases of testicular
escent. Inguinoscrotal descent is mediated by androgens
ince this phase fails to occur in some humans or animals
ith mutations in the androgen receptor that cause andro-
en resistance (Hutson, 1986) or with defects in androgen
ynthesis (Grocock et al., 1988). In rats, impaired inguino-
crotal descent can be elicited by prenatal blockade with
nti-androgens (Husmann and McPhaul, 1991; Spencer et
l., 1991). The first phase of testicular descent (transab-
ominal phase), however, does not require androgens as it is
ormal in eutherian mammals with androgen deficiency or
esistance (Griffin and Wilson, 1980; Hutson, 1986). The
actor promoting transabdominal testicular descent via con-
raction and outgrowth of the gubernaculum remained
nknown for decades. This hormone, which received
ames such as “factor X” (Habenicht and Neumann, 1983),
third hormone” (van der Schoot et al., 1995), or even
descendin” (Fentener et al., 1988), was thought to be
xpressed by the testes and to promote gubernaculum
utgrowth and contraction. This factor was recently iden-
ified as insulin-3 (Insl3) based on studies in gene knockout
ice (Nef and Parada, 1999; Zimmermann et al., 1999).
The insulin-3 gene product, also known as Leydig
nsulin-like hormone or relaxin-like factor, is part of the
nsulin family which includes insulin, relaxin, insulin-
ike growth factors I and II, insulin-4 (or EPIL) (Chassin et
l., 1995), insulin-5 (Conklin et al., 1999) or RIF-2 (Hsu,
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355Molecular Basis for Estrogen-Induced Cryptorchidism1999), and insulin-6 (Kasik et al., 2000) or RIF-1 (Hsu,
1999). The mature Insl3 peptide, like insulin, is com-
posed of A and B chains linked by disulfide bonds (Adham
et al., 1993). Insl3 expression is sexually dimorphic
(Zimmermann et al., 1997). In male mice, Insl3 tran-
scripts are first detected at E13.5 in Leydig cells, and
levels remain constant until postnatal sexual maturation
and initiation of spermatogenesis, at which time a second
increase in transcript levels is observed. In females, Insl3
transcripts are first detected at postnatal day 6 (P6) in
theca and luteal cells of the ovary (Balvers et al., 1998).
Mice homozygous for an Insl3 gene deletion are viable
ut exhibit bilateral cryptorchidism, abnormal guber-
acular development, and spermatogenesis defects and
re infertile. Steroidogenic factor 1 (SF-1) appears to be
nvolved in regulation of Insl3 transcription (Zimmer-
ann et al., 1998). SF-1 is an orphan nuclear receptor that
egulates the expression of several genes in testes, ova-
ies, adrenals, and pituitaries (Wong et al., 1997).
Abnormal estrogen action has been implicated as a pos-
ible cause for sporadic cryptorchidism in humans. Several
bservations have been posited to support this theory. First,
reatment of pregnant women with diethylstilbestrol (DES),
nonsteroidal estrogenic substance, is associated with
ndescended testis in male offspring (Gill et al., 1979). In
ddition, nausea in early pregnancy, which is thought to
esult from high estrogen levels, is associated with an
ncreased incidence of impaired testicular descent (Hender-
on et al., 1979). Moreover, one clinical study showed that
others of cryptorchid children had higher levels of free
stradiol during the first trimester versus mothers whose
ffspring had normally descended testes (Bernstein et al.,
988). Finally, Hadziselimovic and colleagues (1999) dem-
nstrated an increased expression of estradiol in placenta of
oys with cryptorchid testes.
Animal studies support the human correlations. In mice,
n utero exposure to estradiol induces cryptorchidism. In-
eed, the main experimental model for intra-abdominal
ryptorchidism involves exposure of pregnant rodents to
xogenous estrogens (Grocock et al., 1988; Hadziselimovic
and Girard, 1977; Hutson, 1992; Khan et al., 1998; Perez et
al., 1996; van der Schoot, 1992). The effects of estradiol
include a reduction of gubernacular outgrowth, the induc-
tion of estrogen receptors within the Wolffian ducts, and
the stabilization of the Mullerian ducts. Finally, male mice
lacking estrogen receptors have overdeveloped cremaster
muscles of the gubernaculum (Donaldson et al., 1996). This
outcome is consistent with the notion that estrogen nor-
mally inhibits the development of the cremasteric muscles
and therefore may impede testicular descent.
Since both the absence of Insl3 and in utero exposure to
exogenous estrogen induce bilateral cryptorchidism in new-
borns, we investigated the possible relationship between
these hormones using the estrogen-induced cryptorchidism
model. Our data provide the first molecular link concerning
estrogen-induced cryptorchidism and support the hypoth-
Copyright © 2000 by Academic Press. All rightsis that excess estrogen may be a causal factor in improper
esticular descent.
MATERIALS AND METHODS
Steroid hormone-treated mice. Five- to six-week CD1 females
were mated and presence of vaginal plug was counted as day E0.5.
E13.5 pregnant females received a subcutaneous injection of 0.2 ml
dimethyl sulfoxide (DMSO) alone or containing 6 mg of one of the
following steroids: 17a-estradiol, 17b-estradiol, estriol, progester-
ne, 17a-hydroxyprogesterone, hydrocortisone. In the case of DES,
20 mg in 0.2 ml DMSO was injected at E11.5, E13.5, and E15.5 of
gestation. The time of hormonal treatment was selected because
E13.5 corresponds to the beginning of sexual development and also
from previous similar studies (Grocock et al., 1988; Hadziselimovic
and Girard, 1977). 17b-Estradiol-treated females failed to deliver
normally; cesarean sections were performed on E19 and pups were
fostered to surrogate females. Male offspring were killed at E17.5,
P0, P7, P20, and P42. For the dose–response experiment, pregnant
females at 13.5 dpc received a single injection of 0.2 ml of DMSO
with decreasing amounts of 17b-estradiol (6 mg, 1 mg, 500 mg, 100
mg, and 20 mg).
Scanning electronic microscopy. CD1 treated and untreated
E17.5 embryos and P0 pups were decapitated and fixed overnight in
2.5% glutaraldehyde, 4% paraformaldehyde in a phosphate-
buffered solution. After fixation, the specimens were dissected to
expose the urogenital organs and the gubernaculum. The samples
were then processed for SEM by rinsing twice in 0.1 M phosphate
buffer, fixing in 0.1% osmium tetroxide for 1.5 h, and dehydrating
through a gradient of EtOH. The tissues were dried using a Denton
DCP-1 critical point drying apparatus, carbon-coated in the sputter
coater, and viewed in the scanning electron microscope (JEOL JSM
840A SEM).
Histology and in situ hybridization. Pregnant mice were al-
lowed to deliver or offspring were delivered by cesarean section on
day 19 of gestation for mice treated with 17a-estradiol, 17b-
estradiol, or DES. The abdominal cavity of neonates was opened,
the positions of testes were recorded, and the whole embryo was or
isolated tissues were fixed in Bouin’s solution overnight. After
fixation, the samples were dehydrated and embedded in paraffin.
Seven-micrometer sections mounted on coated slides were stained
with hematoxylin and eosin as described (Liebl et al., 1997) or
processed for in situ hybridization as described (Nef and Nef, 1997).
35S-labeled radioactive antisense cRNA was produced by in vitro
transcription with T3, T7, or Sp6 RNA polymerases. The mouse
antisense Insl3 cRNA probe is a 369-bp fragment comprising the
ull coding region of the Insl3 cDNA. The mouse antisense SF-1
robe was produced from a 502-bp cDNA fragment corresponding
o the first 502 bp of the SF-1 cDNA (gift from K. L. Parker), and the
ouse antisense probe for the cholesterol side-chain cleavage
ytochrome P450 (P450scc) was produced from a 700-bp fragment
orresponding to the first 700 bp of the P450scc cDNA. The
sections were exposed 7 days in Kodak emulsion NTB2 and then
developed, fixed, stained with toluidine blue, and mounted.
Northern blots. Total RNA was extracted using Trizol solu-
tion (Gibco BRL) and analyzed by Northern blot for Insl3 and
glyceraldehyde-3-phosphate dehydrogenase (G3PDH) transcripts.
Ten micrograms of denaturated total RNA from tissues or cell lines
was electrophoresed on a 1.5% formaldehyde/agarose gel and
transferred to nylon membrane (Hybond N1). Hybridization was
performed with the NorthernMax prehybridization/hybridization
s of reproduction in any form reserved.
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356 Nef, Shipman, and Paradabuffer (Ambion) using the manufacturer’s protocol. Probes were
generated by random primer labeling using dCTP. Autoradiography
was performed with an intensifying screen overnight at 270°C.
Blots were then stripped of the remaining radioactivity by rinsing
the membranes twice with a boiling 0.5% SDS (v/w) solution,
rehybridized with a G3PDH-specific probe to determine the quan-
tity of RNA loaded, and exposed overnight at 270°C.
RESULTS
Mice Exposed in Utero to 17b-Estradiol Have
Cryptorchid Testes
Pregnant mice received a subcutaneous injection of 6 mg
of 17b-estradiol on E13, corresponding to the beginning of
male sexual differentiation in the gonad (Grocock et al.,
1988; Hadziselimovic and Girard, 1977). SEM analysis of
untreated E17.5 male embryos (Fig. 1A) showed a well-
developed gubernacular bulb and a contracted gubernacular
cord, whereas the gubernaculum of 17b-estradiol-treated
embryos (Fig. 1B) displayed a small bulb and an elongated
cord. The testes of untreated neonate male mice (Fig. 1C)
are localized beneath the bladder neck and proximal to the
inguinal region. The once swollen gubernacular bulbs have
regressed and appear embedded in the peritoneal hollow
(see arrowheads), where they will ultimately draw the
testes through the inguinal canal after birth. In contrast
(Fig. 1D), neonates previously exposed to 17b-estradiol
show the testes located above the bladder neck or, in some
cases, just below the kidney in a position similar to that of
the ovaries. These are classical examples of impaired tes-
ticular descent (cryptorchidism). As previously described,
excess estrogen also causes retention of the Mullerian ducts
and feminized or undeveloped gubernaculae, which likely
explains the intra-abdominal localization of the testes.
Except for the stabilization of the Mullerian structures, the
urogenital anatomy of mice treated with 17b-estradiol
shares striking features with Insl3 2/2 mice (Nef and
Parada, 1999; Zimmermann et al., 1999). Both displayed
intra-abdominal testes and feminized gubernaculae.
17b-Estradiol Regulates Insl3 Transcription in
mbryonic Leydig Cells
The similar phenotypes (undifferentiated gubernaculum
and intra-abdominal cryptorchidism) of Insl3 2/2 and
7b-estradiol-exposed male mice prompted us to examine
he possibility that fetal estrogen exposure may interfere
ith Insl3 action. We therefore performed in situ mRNA
ybridization on testis from normal and 17b-estradiol-
treated neonatal (P0) mice using an Insl3-specific probe. In
untreated testes, Insl3 transcripts were abundant in Leydig
ells (Nef and Parada, 1999). In contrast, we were unable to
etect Insl3 transcripts in the testes of males exposed to
17b-estradiol in utero (compare Figs. 2C and 2D). Histolog-
cal examination of the estradiol-treated testes revealed
ormal Leydig cell numbers and morphology (Figs. 2A and
B). To examine gene expression in Leydig cells we per- m
Copyright © 2000 by Academic Press. All rightormed in situ mRNA hybridization for the cholesterol
ide-chain cleavage cytochrome P450 mRNA, a specific
arker for Leydig cells. Expression of P450scc was the same
n Leydig cells from both treated and untreated testes (Figs.
E and 2F). The expression of Desert hedgehog, a specific
FIG. 1. SEM of the urogenital anatomy of E17.5 and neonate male
pups treated with 17b-estradiol. Pictures of (A and C) untreated
males compared to (B and D) 17b-estradiol-treated males at E17.5
(A and B) and P0 (C and D). (A) At E17.5 the male gubernaculum is
swollen and contracted and the testes are located slightly above the
bladder neck. (B) In contrast, in the 17b-estradiol-treated embryos
the gubernaculum is completely feminized with a very thin and
elongated cord similar to female gubernaculum. (C) At P0, the
testes of untreated neonate pups have migrated below the bladder
neck, and the gubernaculum, which has regressed and inverted, is
embedded within the peritoneal hollow (arrowheads). (D) The
testes of 17b-estradiol-treated males are clearly cryptorchid and
located above the bladder neck. The gubernaculum is thin and
elongated, similar to female gubernaculum. There is no peritoneal
hollow. The bladder has been surgically removed to ensure better
accessibility. Abbreviations: BN, bladder neck; G, gubernaculum;
GB, gubernacular bulb; T, testes.arker for Sertoli cells, is normal in estradiol-exposed
s of reproduction in any form reserved.
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357Molecular Basis for Estrogen-Induced Cryptorchidismtestes (data not shown). These data indicate that estrogen-
exposed testes differentiated normally and that general gene
transcription in Leydig and Sertoli cells was normal, while
Insl3 transcription was severely altered.
The SF-1 gene has been reported to control transcription
of Insl3 (Zimmermann et al., 1998). We observed normal
levels of SF-1 transcripts in estradiol-exposed Leydig cells
despite the fact that Insl3 expression was abolished (Figs.
2G and 2H). These data indicate that Insl3 transcriptional
blockade was specific and not mediated by SF-1. Thus,
exposure of male embryos to unusually high levels of
estradiol resulted in specific blockade of Leydig cell Insl3
gene expression.
Developmental Insl3 Expression
Insl3 transcript levels were affected throughout develop-
FIG. 2. In situ hybridization of untreated and 17b-estradiol-
reated testes. (A, C, E, and G) Untreated and (B, D, F, H)
7b-estradiol-treated testes sections were stained with (A and B)
hematoxylin and eosin or hybridized with an antisense probe for
Insl3 (C and D) or P450scc (E and F) or SF-1 (G and H). Note the
bsence of Insl3 transcripts in 17b-estradiol-treated males but the
resence of P450scc transcripts, which indicates that the Insl3 gene
s specifically blocked by the 17b-estradiol treatment.ment by exposure to estradiol (Fig. 3A). Postnatally, how-
Copyright © 2000 by Academic Press. All rightver, Insl3 expression was normal in prenatally estradiol-
xposed males (Fig. 3A). The reemergence of Insl3
ranscripts between P0 and P7 coincided with the replace-
ent of fetal-type Leydig cells by a new adult-type Leydig
ell population (Balvers et al., 1998; Huhtaniemi and Pel-
iniemi, 1992). Thus, Insl3 expression appeared to be per-
anently and specifically blocked in fetal-type Leydig cells
y exposure to a single bolus of exogenous estradiol. Insl3
ranscripts reappeared only in the new adult-type Leydig
ell population that was exposed to 17b-estradiol in the
ifferentiated state.
FIG. 3. (A) Time course of Insl3 expression in 17b-estradiol-
reated testes. 10 mg of total RNA from testes untreated (2) or
7b-estradiol-treated (E2) at different stages were hybridized
against a specific probe for the Insl3 gene. At E17.5 and P0 the Insl3
expression is completely blocked but at P7, P20, and P42 the
expression of the Insl3 gene is similar in treated and untreated
estes. (B) Dose–response analysis of Insl3 gene expression in mice
reated with decreasing amounts of 17b-estradiol. 10 mg of total
NA from P0 testes untreated (WT) or treated with the vehicle
MSO or decreasing amounts of 17b-estradiol were hybridized
gainst a specific probe for the Insl3 gene. The minimum quantity
o block Insl3 gene transcription is 500 mg (15 mg 17b-estradiol per
ram of tissue). (C) Northern blot analysis of Insl3 gene expression
n 17b-estradiol, 17a-estradiol, DES, or estriol-treated testes. 10 mg
of total RNA from P0 testes untreated (WT) or treated with the
vehicle DMSO, 17b-estradiol, 17a-estradiol, or DES was hybridized
against a specific probe for the Insl3 gene. Note the blockade of
Insl3 expression in 17b-estradiol-, 17a-estradiol-, estriol-, and DES-
treated testes.
s of reproduction in any form reserved.
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358 Nef, Shipman, and ParadaTypically, experimental cryptorchidism is produced by
intraperitoneal injection of 1–6 mg estradiol into a pregnant
female (40–240 mg/g of tissue). These artificially high con-
entrations ensure saturation and reproducibility under
xperimental conditions, but have limited implications for
echanisms of sporadic cryptorchidism. We therefore per-
ormed a dose–response experiment to determine the mini-
um quantity of 17b-estradiol necessary and sufficient to
lock Insl3 gene transcription when applied as a single dose
at E13.5. Northern blot analysis of total RNA from testes
treated with decreasing amounts of estradiol show that
Insl3 transcripts were absent or markedly reduced after
treatment with 6 mg, 1 mg, and 500 mg but were present at
100 mg of 17b-estradiol (Fig. 3B). Therefore, 17b-estradiol
doses in the range of 20 mg per gram of tissue (500 mg of
17b-estradiol/30 g pregnant female) were sufficient to re-
roducibly block Insl3 gene transcription after an acute
xposure. In each case, the reduction in Insl3 transcripts
orrelated with the intra-abdominal localization of the
estes (data not shown), indicating that the presence of Insl3
ormone was necessary for normal testicular descent and
hat exposure to estrogen can impede its action. The con-
equences of chronic exposure to estrogens at lower con-
entrations may further reduce the level required for bio-
ogical effect.
Estrogen-Related Molecules and Nonsteroidal
Estrogens Induce Cryptorchidism via Insl3
Regulation
It has been hypothesized that estrogen-related mol-
ecules, including so-called environmental or xenoestro-
gens, may be responsible for the increasing incidence of
sporadic cryptorchidism. To obtain experimental evi-
dence in support of this idea, we next tested whether the
estrogen stereoisomer 17a-estradiol and the related es-
triol, two molecules known to have reduced estrogenic
activity, have effects on Insl3 gene transcription and the
development of the gubernaculum and testicular descent.
In addition, the nonsteroidal synthetic estrogen DES was
tested in this assay. Northern blot analyses performed
with total RNA from untreated or 17a-estradiol-, 17b-
estradiol-, estriol-, and DES-treated testes at P0 indicated
that Insl3 transcripts were absent in 17b-estradiol- and
estriol-treated testes or significantly reduced in 17a-
estradiol and DES-treated testes (Fig. 3C). SEM analysis
of neonatal male embryos treated with estrogenic sub-
stances displayed intra-abdominal testes and thin, elon-
gated gubernaculae (see Fig. 4; compare the gubernaculae
of treated and untreated neonate pups). The peritoneal
hollows were also absent in treated pups. Again, the
feminized gubernaculae were similar to those observed in
Insl3 2/2 neonatal mice (Nef and Parada, 1999; Zimmer-
mann et al., 1999) and explained the intra-abdominal
localization of the testes. Insl3 transcripts levels were
unaffected in vehicle (DMSO)-treated testes. Thus,
estrogen-related compounds that have been reported to t
Copyright © 2000 by Academic Press. All rightave reduced estrogen activity in other assays can pro-
ote cryptorchidism in mice through down regulation of
he Insl3 gene. In addition, partial Insl3 blockade was
ufficient to retard gubernacular development.
To determine whether the effect on Insl3 expression was
general feature of steroid hormones, pregnant females
ere exposed to progesterone, 17a-hydroxyprogesterone,
and hydrocortisone under the same conditions. Neither
steroid had any effect on intra-abdominal testicular descent
(data not shown). Thus, Insl3 blockade appears specific to
estrogen-like substances that likely act through estrogen
receptors a or b or some novel estrogen receptor and not
FIG. 4. SEM of the urogenital anatomy of neonates (A) untreated
or treated with (B) estriol, (C) 17a-estradiol, or (D) DES. In each
case, note the feminization of the gubernaculum, the intra-
abdominal localization of the testes, and the absence of peritoneal
hollow. The bladder has been surgically removed to ensure better
accessibility. Abbreviations: BN, bladder neck; G, gubernaculum;
T, testes.hrough a nonspecific effect.
s of reproduction in any form reserved.
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359Molecular Basis for Estrogen-Induced CryptorchidismDISCUSSION
The purpose of this study was to determine the relation-
ship between estrogens, Insl3 expression, and testicular
descent. The data unambiguously show that in utero expo-
sure to 17a-estradiol, 17b-estradiol, estriol, or DES nega-
tively regulates Insl3 gene expression. Histological exami-
nation of the cryptorchid Leydig cells, as well as normal
expression of additional genes, suggests that Insl3 blockade
is not caused by general metabolic depression in these cells.
Estrogens are produced mainly in gonads and some periph-
eral tissues. These hormones are cell-membrane permeable,
but are retained with high affinity and specificity in target
cells expressing the estrogen receptor (ER). The
estrogen–ER complex undergoes a conformational change
allowing the receptor to bind with high affinity to chroma-
tin and modulate the expression of target genes. Analysis of
the Insl3 proximal promoter (Zimmermann et al., 1998) did
ot reveal sequences obviously related to estrogen-response
lements. Thus, either the entirety of in vivo Insl3 cis-
egulatory sequences has not yet been identified or the
7b-estradiol effect is not mediated by direct inhibiting
nteraction by ERa. Inhibition of Insl3 transcription may be
mediated via indirect ER transcriptional control of Insl3
regulatory genes other than SF-1. The reported Insl3 pro-
moter possesses four consensus binding sites for SF-1, and
mutations in any of these sites abolish Insl3 transcription
in a mouse tumor cell line (MA-10), indicating that in these
cells, the Insl3 gene is under direct control of SF-1 (Zim-
mermann et al., 1998). However, our data indicate that the
effects of estrogens on Insl3 expression in fetal Leydig cells
are not related to alteration in SF-1 expression. High levels
of estrogen result in the abolition of Insl3 expression
without affecting SF-1 expression or its function on the
P450scc gene (Clemens et al., 1994).
In utero exposure to exogenous estradiol causes several
effects on paratesticular structures. In addition to bilateral
intra-abdominal cryptorchidism, there is stabilization of
the Mullerian ducts. Persistence of Mullerian structures is
unrelated to Insl3 transcription since Insl3 2/2 male mice
have normal vas deferens and no evidence of a uterus (Nef
and Parada, 1999; Zimmermann et al., 1999). A likely
explanation for the persistence of Mullerian structures in
these mice is that, independent of their action on Insl3,
estrogens also block Wnt7a gene transcription. Previous
work has shown that DES is able to block Wnt7a gene
transcription (Miller et al., 1998). Wnt7a is required for
Mullerian inhibiting substance receptor expression, and its
absence blocks receptor expression and subsequent regres-
sion of the Mullerian structures (Parr and McMahon, 1998).
The phenotype of estrogen-treated mice is strikingly
similar to that of Insl3 mutant mice. Despite the fact that
estradiol is known to inhibit androgen production and that
androgens have been implicated in testicular descent, the
intra-abdominal position of the testes in estrogen-treated
mice is due to the absence of Insl3 hormone but not of
androgens. Estrogens block the first phase of testicular p
Copyright © 2000 by Academic Press. All rightdescent (transabdominal descent), which is controlled hor-
monally by Insl3 (Nef and Parada, 1999; Zimmermann et
al., 1999), whereas androgens control only the second phase
(inguinoscrotal descent; Hutson et al., 1994). In fact, estro-
gen exposure does not block outgrowth of the gubernacu-
lum by acting as an anti-androgen since neonatal male mice
treated with the anti-androgen flutamide display normal
gubernacular development with complete transabdominal
descent (Shono et al., 1996).
Estrogens inhibit androgen production either by limiting
the development and growth of Leydig cells or by directly
inhibiting the activities of several steroidogenic enzymes
involved in testosterone synthesis (for review see Abney,
1999). Estradiol is produced not only by the mother but also
in significant amounts by Sertoli cells (Dorrington and
Armstrong, 1975; Pomerantz, 1980). In addition, testes
concentrate estradiol as much as 10- to 50-fold higher than
in peripheral blood (Kelch et al., 1972). Normal buffering
mechanisms control the concentration of free estradiol in
Leydig cells. First, estradiol and estrone bind with high
affinity to a-fetoprotein, a protein present in high quantities
in fetal serum (Keel and Abney, 1984; Nunez et al., 1974). In
addition, the presence of an estrogen sulfotransferase in
Leydig cells has been reported (Hobkirk and Glasier, 1992;
Song et al., 1995), which may facilitate the catabolism of
estrogen. Evidently, abnormally high levels of free estradiol
or related estrogenic molecules can overcome the buffering
mechanism leading to reduce Insl3 transcription.
Blockade of Insl3 gene transcription by in utero exposure
to estrogens occurs during neonatal development. The
reappearance of Insl3 transcripts coincides with the replace-
ment of fetal Leydig cells by an adult population (Balvers et
al., 1998; Huhtaniemi and Pelliniemi, 1992). Adult Leydig
cells do not down regulate Insl3 gene transcription upon
estrogen exposure (data not shown). Therefore, the differ-
entiation switch associated with replacement of the fetal
with the adult-type cell population between P5 and P15 also
corresponds to a change in Insl3 gene regulation. Fetal
Leydig cells express Insl3 in a gonadotropin-independent
fashion and are estrogen-sensitive, whereas Insl3 expres-
sion is estrogen independent but gonadotropin dependent in
the adult population (Balvers et al., 1998).
The main argument against estrogens as potential factors
n impaired testicular descent is the lack of persistent
ullerian structures in affected humans (Heyns and Hut-
on, 1995). In rodents, estrogen-induced cryptorchidism is
btained by injecting pregnant females with 1–6 mg of
stradiol at 13.5 dpc (Grocock et al., 1988; Hadziselimovic
nd Girard, 1977). This represents supraphysiologic
mounts of estrogen, which in no case represent a normal in
ivo state. A likely scenario for the effectiveness of this
xperimental strategy is the saturation of any potential
elevant target. If estrogens underlie sporadic cryptorchid-
sm, then it is likely that these effects are mediated by
maller doses localized to the correct target tissue at the
recise time, thus achieving maximal effect. It may be
ossible that a small excess of free estradiol at the right
s of reproduction in any form reserved.
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360 Nef, Shipman, and Paradadevelopmental stage (i.e., during the first trimester in
human) may have a strong impact on testicular descent. It
is well known that testes concentrate estradiol and it is
generally agreed that estrogens have a dramatic, usually
inhibitory, influence on cell function (Abney, 1999). There-
fore, it seems reasonable to postulate that subtle differences
in estrogen levels may alter Insl3 transcription and impact
testicular descent.
External factors, such as natural or synthetic molecules
with estrogenic activities (xenoestrogens), may disrupt the
normal endocrine balance and cause demasculinization and
feminization effects in the developing male embryo. It has
been widely speculated that the increased presence in the
environment of xenoestrogens in the past 50 years may be
the cause for declining male reproductive health such as the
increased incidence of testicular cancer, cryptorchidism,
hypospadias, and a lowered sperm count (Jensen et al., 1995;
oppari, 1998). A classic example of the effects of a xe-
oestrogen is DES, which was prescribed during the late
940s to early 1970s to pregnant women to prevent abor-
ion, preeclampsia, and other complications of pregnancy.
aughters of women treated with the drug during preg-
ancy have a high risk of developing clear cell adenocarci-
oma of the vagina, while male offspring are at risk of
eveloping multiple reproductive defects including cryp-
orchidism, epididymal cysts, low sperm counts, and tes-
icular cancers (Gill et al., 1979; Herbst et al., 1971, 1979;
Wilcox et al., 1995). Here we show that DES is able to
nduce intra-abdominal cryptorchidism and block Insl3
ene transcription. These data likely explain the higher
roportion of cryptorchidism in boys whose mothers were
reated with DES during pregnancy and suggest that the
nsl3 gene may be a potential target for endocrine disrupters
ith estrogenic activities. We hope that these results will
rigger a reexamination of estrogens as potential mediators
f cryptorchidism. While this article was in completion,
mmen et al. (2000) reported DES-mediated regulation of
nsl3 transcripts. Their report is in agreement with ours and
e extend the findings to include additional estrogens and
o demonstrate the specificity of the blockade. Further
tudies to elucidate the mechanism by which estrogens
lock Insl3 transcription are clearly warranted.
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